Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELU42 for Wagner Grade 1-2 Diabetic Foot Ulcers
NCT07396376Phase 2Recruiting
- Sponsor
- Eluciderm
- Start
- Nov 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ELU42 in diabetic foot ulcer (DFU), sponsored by Eluciderm. Started Nov 2025; status: recruiting.
02
Drugs
ELU42
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT07396376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07396376.